Advertisement
U.S. markets open in 3 hours 1 minute

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
40.73+0.65 (+1.62%)
At close: 04:00PM EDT
40.43 -0.30 (-0.74%)
After hours: 04:04PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close40.08
Open40.51
Bid40.64 x 200
Ask40.75 x 400
Day's Range40.33 - 40.94
52 Week Range29.85 - 45.00
Volume527,551
Avg. Volume1,352,468
Market Cap5.175B
Beta (5Y Monthly)1.25
PE Ratio (TTM)19.40
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
62% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HALO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Halozyme Therapeutics, Inc.
    HALO: Lowering target price to $42.00HALOZYME THERAPEUTICS INC has an Investment Rating of HOLD; a target price of $42.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more